Spartan 1 (Mod GRF 1-29/CJC-1295 No Dac + Hexarelin)

Description

Overview

This research stack is an investigational peptide formulation composed of two synthetic peptides: Mod GRF 1-29 (also known as CJC-1295 without Drug Affinity Complex) and Hexarelin. The formulation combines peptides associated with growth hormone regulatory pathways, enabling controlled examination of endocrine signaling in experimental systems.

In experimental models, the peptide combination provides a framework for investigating interactions between GHRH receptor signaling and ghrelin-receptor-mediated pathways, particularly in studies examining pulsatile endocrine signaling and intracellular signaling cascades.

Mod GRF 1-29 (CJC-1295 No DAC)

Mod GRF 1-29, also referred to as CJC-1295 without DAC, is a modified analog derived from the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). The 1-29 sequence represents the biologically active portion of the native hormone responsible for receptor binding and signal initiation.

Structural modifications within Mod GRF 1-29 were introduced to enhance resistance to enzymatic degradation while preserving receptor affinity. In investigational research, this peptide is frequently utilized to examine GHRH receptor signaling pathways, receptor-ligand interactions, and intracellular signaling mechanisms associated with endocrine regulation.

Chemical and Molecular Properties

Property	Verified Data
Chemical Name	Modified Growth Hormone Releasing Factor (1‑29)
Synonym	CJC-1295 No DAC
CAS Number	446262-90-4
Molecular Formula	C152H252N44O42
Molecular Weight	~3367.9 g/mol
Peptide Length	29 amino acids
Classification	Synthetic GHRH analog peptide

Working Mechanism

Mod GRF 1-29 acts as a ligand for the growth hormone-releasing hormone receptor (GHRHR), a G-protein-coupled receptor expressed in endocrine research models.

In experimental systems, the mechanism can be summarized as follows:

1. Receptor Binding
   Mod GRF 1-29 binds to the extracellular domain of the GHRH receptor, initiating receptor activation.
   
2. Gs Protein Activation
   The activated receptor stimulates Gs protein signaling, leading to activation of adenylyl cyclase.
   
3. cAMP Production
   Adenylyl cyclase catalyzes the conversion of ATP to cyclic adenosine monophosphate (cAMP), increasing intracellular cAMP levels.
   
4. PKA Signaling Cascade
   Elevated cAMP activates protein kinase A (PKA), which subsequently phosphorylates downstream signaling proteins and transcription factors.
   
5. Intracellular Signaling Regulation
   These signaling events influence molecular pathways involved in endocrine signal transduction and transcriptional regulation within experimental models.
   

Because of its shorter receptor engagement window relative to DAC-modified analogs, Mod GRF 1-29 is often utilized in research examining rapid signaling responses and pulsatile endocrine signaling mechanisms.

Hexarelin

Hexarelin is a synthetic hexapeptide growth hormone secretagogue belonging to a class of compounds designed to interact with the growth hormone secretagogue receptor (GHSR). Structurally related to ghrelin mimetics, Hexarelin has been widely studied in experimental research exploring receptor signaling pathways associated with endocrine regulation.

Due to its defined peptide structure and high receptor affinity, Hexarelin is frequently used in investigational models examining ghrelin-receptor activation, ligand-receptor interactions, and intracellular signaling cascades triggered by secretagogue peptides.

Chemical and Molecular Properties

Property	Verified Data
Chemical Name	Hexarelin
Classification	Growth Hormone Secretagogue Peptide
CAS Number	158861-67-7
Molecular Formula	C45H55N9O6
Molecular Weight	~818.0 g/mol
Peptide Length	6 amino acids

Working Mechanism

Hexarelin functions primarily as an agonist of the growth hormone secretagogue receptor type 1a (GHSR‑1a), a G-protein-coupled receptor involved in endocrine signaling pathways.

In investigational studies and experimental models, the mechanism generally includes the following molecular events:

1. Receptor Interaction
   Hexarelin binds to the GHSR-1a receptor, triggering receptor activation.
   
2. G-Protein Signaling Activation
   Receptor activation stimulates intracellular Gq/11 protein signaling pathways.
   
3. Phospholipase C Activation
   Activated G-proteins stimulate phospholipase C (PLC).
   
4. Second Messenger Generation
   PLC catalyzes the production of intracellular signaling molecules inositol triphosphate (IP3) and diacylglycerol (DAG).
   
5. Intracellular Calcium Signaling
   IP3 stimulates the release of calcium ions from intracellular stores, resulting in increased cytosolic calcium concentrations, which act as secondary messengers within signaling pathways.
   
6. Additional Receptor Pathways
   Some experimental research has indicated potential interactions with CD36 receptors, suggesting additional molecular signaling roles in certain research models.
   

These intracellular events make Hexarelin a useful compound in experimental studies of ghrelin‑receptor signaling, second-messenger pathways, and peptide-receptor pharmacology.

Research Applications in Laboratory Settings

Endocrine Signaling Research

Experimental models may use the peptide blend to study:

• GHRH receptor signaling pathways
  
• GHSR-1a receptor activation mechanisms
  
• Interactions between endocrine regulatory peptides
  

These studies frequently involve cell-based assays, receptor binding experiments, and signaling pathway analyses.

Pulsatile Hormone Signaling Models

The relatively short activity window associated with Mod GRF 1-29 allows investigation of:

• Pulsatile signaling kinetics
  
• Transient receptor activation
  
• Temporal regulation of endocrine signaling cascades
  

Such models may be explored using in vitro endocrine cell cultures or receptor‑expressing research systems.

Peptide-Receptor Interaction Studies

Hexarelin's interaction with GHSR-1a and potential alternative receptor targets allows investigation into:

• Receptor binding affinity
  
• Ligand-induced intracellular signaling pathways
  
• Structure-activity relationships of ghrelin mimetics
  

These investigations contribute to broader research into synthetic peptide signaling modulators.

Experimental Models of Intracellular Signal Transduction

The dual-peptide system provides a platform for examining:

• cAMP-dependent signaling pathways
  
• calcium-mediated intracellular signaling
  
• transcriptional regulation associated with endocrine signaling networks
  

Such studies typically involve biochemical assays, receptor-binding experiments, and molecular pathway analysis.

Why Choose Purerawz for Mod GRF 1-29 (CJC-1295 No DAC) + Hexarelin?

Buy Mod GRF 1-29 (CJC-1295 No DAC) + Hexarelin for laboratory research use from our online shop. At Purerawz, we provide high-quality reference materials. Each research compound comes with a Certificate of Analysis for verification of purity and concentration.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

Reference Links

• Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477. https://doi.org/10.1016/j.ghir.2009.03.001
• Guan, C., Li, C., Shen, X., Yang, C., Liu, Z., Zhang, N., Xu, L., Zhao, L., Zhou, B., Man, X., Luo, C., Luan, H., Che, L., Wang, Y., & Xu, Y. (2023). Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. European Journal of Medical Research, 28(1), 344. https://doi.org/10.1186/s40001-023-01318-w